COSRX Niacinamide 15% Face Serum, Minimize Enlarged Pores, Redness Relief, Blemish & Discoloration Correcting Treatment, 0.67 fl.oz/20 ml, Not Tested on Animals, Korean Skincare

Amazon.com Price: $15.50 (as of 12/09/2023 22:32 PST- Details)

Redness Relieving Serum: Refine Pores, Smoothen Skin, Relieve Redness. The Niacinamide and Zinc PCA instantly improves skin texture and radiance by reducing excess oil and minimizing pore sizes.
Key Benefits: Based on real results from consumers’ self assessments, the Niacinamide 15 Serum minimizes pore size, improves skin texture, and helps fade dark spots.
Dermatological Ingredients: 15% Niacinamide helps minimize enlarged pores and refine uneven skintone. Zinc PCA prevents potential breakouts from occurring.

See Price
Category:

Redness Relieving Serum: Refine Pores, Smoothen Skin, Relieve Redness. The Niacinamide and Zinc PCA instantly improves skin texture and radiance by reducing excess oil and minimizing pore sizes.
Key Benefits: Based on real results from consumers’ self assessments, the Niacinamide 15 Serum minimizes pore size, improves skin texture, and helps fade dark spots.
Dermatological Ingredients: 15% Niacinamide helps minimize enlarged pores and refine uneven skintone. Zinc PCA prevents potential breakouts from occurring.
How to Use: Shake 1-2 times before use and apply 2-3 drops once or twice daily. For daytime wear, follow up with SPF 30+ sunscreen. Can be applied under the eye area; avoid direct eye contact.
COSRX Standards: All COSRX products are formulated with skin-friendly ingredients that alleviate irritated skin. Hypoallergenic, Dermatologist tested, Animal Testing-FREE, Parabens-FREE, Sulfates-FREE, Phthalates-FREE

Additional information

Brand

Be the first to review “COSRX Niacinamide 15% Face Serum, Minimize Enlarged Pores, Redness Relief, Blemish & Discoloration Correcting Treatment, 0.67 fl.oz/20 ml, Not Tested on Animals, Korean Skincare”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

Main Menu